URIDINE TRIACETATE

Search structure
Trade Names:
Synonyms:
Status: Approved (2015)
Entry Type: Small molecule
Molecule Category: Salt
ATC: A16AX13
UNII: 2WP61F175M
Parent Compound: URIDINE

Structure
InChI Key AUFUWRKPQLGTGF-FMKGYKFTSA-N
Smile CC(=O)OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O
InChI
InChI=1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)/t10-,12-,13-,14-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C15H18N2O9
Molecular Weight 370.31
AlogP -1.14
Hydrogen Bond Acceptor 10.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 5.0
Polar Surface Area 142.99
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 26.0

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Pancreatic Neoplasms 3 D010190 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Esophageal Neoplasms 2 D004938 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Mitochondrial Diseases 1 D028361 ClinicalTrials

Related Entries

Scaffolds

Parent

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Gastrointestinal disorders
21.74
General disorders and administration site conditions
14.78
Injury, poisoning and procedural complications
11.3
Nervous system disorders
11.3
Infections and infestations
6.09
Psychiatric disorders
6.09
Blood and lymphatic system disorders
4.35
Respiratory, thoracic and mediastinal disorders
4.35
Investigations
3.48
Vascular disorders
3.48
Cardiac disorders
2.61
Metabolism and nutrition disorders
2.61
Skin and subcutaneous tissue disorders
2.61

Cross References

Resources Reference
CAS NUMBER 4105-38-8
ChEBI 90914
ChEMBL CHEMBL2107381
DrugBank DB09144
FDA SRS 2WP61F175M
PubChem 20058
SureChEMBL SCHEMBL871011
ZINC ZINC000003843198
CONTENTS